Delivery Order SPE2DB22D9207-SPE2DB25FH5EY
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, which has an ultimate completion date of September 29, 2025, is for Stelara 90 mg/ml syringes—a prescription biologic medication used to treat autoimmune and inflammatory conditions. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The delivery order is for Stelara 90 mg/ml syringes, with an ultimate completion date of August 22, 2025. This award carries no set-aside designation, allowing the vendor to compete on its merits within the broader federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 8, 2025. The delivery order covers Stelara 90 mg/mL syringes, a biologic immunosuppressant medication commonly used to treat autoimmune conditions. The award carries no set-aside designation, and the ultimate completion date is scheduled for August 29, 2025. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $65K by the Defense Logistics Agency on September 5, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order is expected to be completed by September 26, 2025, and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on June 3, 2025. The delivery order, which carries an ultimate completion date of June 25, 2025, covers the supply of Stelara 90 mg/ml syringes for distribution to military healthcare facilities. This award was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for Stelara 90 mg/mL syringes. The award is issued under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency on September 9, 2025. The award is for the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order is scheduled for completion by September 30, 2025, with no set-aside designation applied. The contract leverages DMS...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5EYDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $40,179.29 by the Defense Logistics Agency on September 15, 2025. This delivery order, with an ultimate completion date of October 6, 2025, covers the supply of Stelara 90 mg/mL syringes to support Department of Defense healthcare operations. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent success in securing delivery orders from the Defense Logistics Agency for specialized pharmaceutical products including biologics, prescription medications, and injectable treatments. The company's positioning as a trusted distributor for military healthcare systems reflects its capability to provide firm fixed-price pharmaceutical deliveries with rapid turnaround times. This particular delivery order for Stelara, an immunosuppressant biologic used in treating conditions such as psoriasis and inflammatory bowel disease, represents routine procurement activity under the established IDC relationship between DMS Pharmaceutical Group and the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.2k | 9/15/25 |